Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away from their use.

Porush created the first metered-dose inhaler (MDI) in just two months. By March 1956, the Food and Drug Administration had approved two new aerosol drugs for asthma, as well as Porush’s device ...

ProAir HFA Inhalers provides respiratory relief of bronchospasm and wheezing through metered-dose inhalers. Developed for asthma and COPD management, ProAir HFA includes features like dose ...

There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy ...

Pressurised metered dose inhalers (pMDI) delivering drugs for asthma, chronic obstructive pulmonary disease and other respiratory diseases currently use hydrofluorocarbon (HFC) propellants that ...

Fluticasone propionate, salmeterol (as xinafoate); 45mcg/21mcg, 115mcg/21mcg, 230mcg/21mcg; per inh; metered-dose inhaler; CFC-free. Store at room temperature between 68° F and 77° F (20° C and ...

The use of pressurized metered dose inhalers (pMDIs) for asthma treatment is thought to be one of the biggest contributors to the NHS' carbon footprint, with pMDIs making up 70% of inhalers ...

Conclusions: Flunisolide HFA, at one-third the daily dose (median daily dose of 340µg ... concerns [4] provided the impetus to develop new inhaler technologies that can significantly improve ...

Aim: (1) To compare the efficacy and adverse effects of treatment using nebulizers vs pressurized metered-dose inhalers (MDIs) with or without a spacer/holding chamber vs dry powder inhalers (DPIs ...

A single daily preventer dose of inhaled corticosteroid (beclomethasone), taken at mid-afternoon, may be the best timing for ...